United Therapeutics is a Buy: strong core growth, a goal of $1B quarterly revenue by 2027, plus catalysts ralinepag & Tyvaso ...

"First they crawled... now they seem to be evolving through information exchange." 🧟 Evolving zombies! Well Go USA has ...

NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.

Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International ...

The fireside chat is scheduled for 1:00 p.m. ET on June 30, 2026, and will be moderated by Matthew Caufield, Senior Research Healthcare Analyst at H.C. Wainwright & Co. FibroBiologics will be ...

Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...

Train to Busan director Yeon Sang-ho returns for another round of zombie horror this year with Colony, hitting theaters on August 28 via Well Go USA. Check out a bloody new trailer right here: ...

Dr. Jessica Maloh to lead Continuing Medical Education session 'The Biology of Breakouts”; Codex Labs to feature its plant-biotech acne portfolio and Decode.Me integrative dermatology platform ...

Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer’s, unlike many names in the ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...